Patricia Fraser

Patricia Fraser has a strong background in drug safety and pharmacovigilance. Patricia is currently the Head of Pharmacovigilance at Nimbus Therapeutics, a position they have held since March 2023. Prior to that, Patricia worked at Ionis Pharmaceuticals, Inc. as the Executive Director of Drug Safety from November 2020 to March 2023. At Ionis Pharmaceuticals, they were responsible for the clinical safety strategy for assigned drug projects and products. Before that, Patricia served as the Global Safety Officer at Sanofi Genzyme from February 2017 to November 2020. Patricia also worked at EMD Serono, Inc. as the Senior Medical Director and Therapeutic Area Head for Fertility and Immunology Global Drug Safety from November 2012 to February 2017.

Patricia Fraser attended Columbia University Vagelos College of Physicians and Surgeons, where they obtained their Doctor of Medicine (M.D.) degree. Patricia later pursued further education at Harvard T.H. Chan School of Public Health, earning a Master's Degree in Biostatistics. Patricia also obtained another Master's Degree in Public Health from the same institution.